The report “Nutraceutical Excipients Market by Functionality (Fillers & Diluents, Coating Agents, Lubricants, and Flavoring Agents), End Product (Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins), Form (Dry and Liquid), and Region – Global Forecast to 2022″, The nutraceutical excipients market is estimated at USD 2.96 Billion in 2017 and is projected to reach a value of USD 4.27 Billion by 2022, at a CAGR of 7.6%. The market is driven by factors such as the growing demand for nutraceuticals and advances in nanotechnology used in imparting new functions to excipients. The major players in the food industry are investing in research & development activities to expand their excipient product portfolios and attract more consumers by providing innovative products at lower prices.

Growing demand for nutraceuticals

Globally, the burden of chronic diseases is rapidly increasing. According to the WHO, in 2015, chronic diseases caused about 3 million deaths, accounting for 5% of all deaths in the year, globally. In addition, the proportion of the burden of non-communicable diseases (NCDs) is expected to increase to 57% by 2020. Moreover, according to the National Center for Chronic Disease Prevention and Health Promotion, in 2012, about 117 million people in the US had one or more chronic health condition and one of four adults had two or more chronic health conditions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247060367

Advances in nanotechnology imparting new functions to excipients

Nanotechnology-enabled drug delivery systems (NDDS) are used to tackle the issue of drug toxicity. There are two major approaches in using nanotechnology as a drug delivery system (DDS). The first is to reduce the size of nutraceutical drug crystals to ensure greater solubility and bioavailability, while the second approach is using some form of nano-carrier for the more effective delivery of the active ingredient.

Poor drug physiochemical properties can be improved by associating the drug with a pharmaceutical carrier. A drug delivery system (DDS) can enhance a drug’s pharmacokinetics and cellular penetration. Moreover, drug delivery system (DDS) may also address obstacles arising from low drug solubility, degradation, fast clearance rates, nonspecific toxicity, and inability to cross biological barriers. Hence, the use of nanotechnology in improving the functionality of excipients is also expected to drive growth of the nutraceutical excipients market.

North America dominated the nutraceutical excipients market in 2016.

North America accounted for the largest market share in 2016. The nutraceutical excipients market is consolidated in North America and dominated by a few companies such as DuPont, Kerry, Cargill, and Ingredion. The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions.

This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It includes profiles of leading companies such as Kerry (Ireland), ABF (UK), DuPont (US), Ingredion (US), and Sensient (US), Roquette Frères (France), Meggle (Germany), Hilmar Ingredients (US), JRS Pharma (Germany), Innophos (US), Cargill (US), and IMCD (Netherlands).

Request for Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=247060367

Critical questions the report answers:

• Where will all these developments take the industry in the mid to long term?
• What are the upcoming commercial prospects for Nutraceutical Excipients?
• What is the impact of binders and coating agents in Nutraceutical Excipients?
• What are the new end products being introduced in Nutraceutical Excipients?
• What are the latest trends in Nutraceutical Excipients?